Rise in demand for serologic analysis and biopsy is evident due to high prevalence of numerous chronic diseases in the geriatric population. Changing demographics (ageing population) across developed ...

BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it obtained the CE mark in Europe for a next-generation blood separation technology that is ...